4Winawer S,Fletcher R,Rex D,Bond J,Burt R,Ferrucci J,Ganiats T,Levin T,Woolf S,Johnson D,Kirk L,Litin S,Simmang C;Gastrointestinal Consortium Panel.Colorectal cancer screening and surveillance:clinical guidelines and rationale-update based on new evidence.
5Bretthauer M,Gondal G,Larsen K,Carlsen E,Eide TJ,Grotmol T,Skovlund E,Tveit KM,Vatn MH,Hoff G.Design,organization and management of a controlled population screening study for detection of colorectal neoplasia:attendance rates in the NORCCAP study (Norweg
6Petersen VC,Baxter KJ,Love SB,Shepherd NA.Identification of objective pathological prognostic determinants and models of prognosis in Dukes'B colon cancer.Gut,2002,51:65-69.
7Lewis JD.Cost-effectiveness of screening for colorectal cancer:the dollar is in the details.Gastroenterology,2003,124:856-858.
8Jorgensen OD,Kronborg O,Fenger C.A randomised study of screening for colorectal cancer using faecal occult blood testing:results after 13 years and seven biennial screening rounds.Gut,2002,50:29-32.
9Mandel JS,Church TR,Bond JH,Ederer F,Geisser MS,Mongin SJ,Snover DC,Schuman LM.The effect of fecal occult-blood screening on the incidence of colorectal cancer.N Engl J Med,2000,343:1603-1607.
10Scholefield JH,Moss S,Sufi F,Mangham CM,Hardcastle JD.Effect of faecal occult blood screening on mortality from colorectal cancer:results from a randomised controlled trial.Gut,2002,50:840-844.
